Results 41 to 50 of about 276,174 (253)

Heart rate variability and target organ damage in hypertensive patients

BMC Cardiovascular Disorders, 2012
Background We evaluated the association between linear standard Heart Rate Variability (HRV) measures and vascular, renal and cardiac target organ damage (TOD).
Melillo Paolo, Izzo Raffaele, De Luca Nicola, Pecchia Leandro   +3 more
doaj   +1 more source

Bridging the Gap in Neuroblastoma Care: Consensus‐Based Statements With Recommendations for Improved Patient and Caregiver Experiences

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Neuroblastoma's complex, heterogeneous biology poses significant diagnostic and therapeutic challenges, often requiring caregivers to absorb complex information and participate in time‐sensitive decisions. However, caregivers often feel unprepared to evaluate options.
Vickie Buenger, Joseph Bauer, Jennifer Diamond, Maggie Fader, Shae Hansen, Jacqueline M. Kraveka, Johanna Schoen, Amber Shearer, Dena Sherwood   +8 more
wiley   +1 more source

Ambulatory arterial stiffness indices and target organ damage in hypertension

BMC Cardiovascular Disorders, 2012
Background The present study was designed to evaluate which arterial stiffness parameter - AASI or the home arterial stiffness index (HASI) - correlates best with vascular, cardiac and renal damage in hypertensive individuals.
Gómez-Marcos Manuel, Recio-Rodríguez José, Patino-Alonso Ma, Gómez-Sánchez Leticia, Agudo-Conde Cristina, Gómez-Sánchez Marta, Rodríguez-Sánchez Emiliano, García-Ortiz Luís   +7 more
doaj   +1 more source

Should Target Organ Damage Become a Therapeutic Target?

The Journal of Clinical Hypertension, 2013
In this issue of the Journal, Shlomai, Grassi, Grossman,and Mancia address the always “hot topic” of targetorgan damage in patients with hypertension in an articleentitled “Assessment of Target Organ Damage in theEvaluation and Follow-Up of the Hypertensive Patients:Where Do We Stand?” The article is thoughtful andinformative, considers the facts and ...
openaire   +3 more sources

Secretory Phospholipase A2 in Patients With Sickle Cell Disease Hospitalized for Vaso‐Occlusive Pain Episodes

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Secretory phospholipase A2 (sPLA2) is an inflammatory mediator linked to acute chest syndrome (ACS) in sickle cell disease (SCD), a serious complication that can develop during an acute vaso‐occlusive pain episode (VOE). Plasma sPLA2 levels have been proposed as a potential biomarker for predicting ACS onset.
Rawan Korman, Maria Yasmine, Dunia Hatabah, Noor Alzraikat, Frank Harris, Lou Ann Brown, Satheesh Chonat, Nitya Bakshi, Chris A. Rees, Carlton Dampier, Claudia R. Morris   +10 more
wiley   +1 more source

Target organ damage in stress-induced arterial hypertension

Кардиоваскулярная терапия и профилактика, 2009
Aim. То investigate the features of target organ damage in patients with stress-induced arterial hypertension (AH).Material and methods. The study included 329 men, aged 29—55 years, with Stage I-II AH. Group I consisted of 197 individuals with workplace
O. N. Antropova, I. V. Osipova, N. А. Lobanova, K. I. Shakhmatova   +3 more
doaj  

P55 TARGET ORGAN DAMAGE AND BLOOD PRESSURE VARIABILITY IN HYPERTENSION

Artery Research, 2017
Purpose/Background/Objectives: Hypertension is associated with several markers of subclinical target organ damage (TOD). Short-term blood pressure variability (SBPV) is a prognostic factor for cardiovascular events in hypertensives.
Dimitrios Terentes-Printzios, Charalambos Vlachopoulos, Athanasios Angelis, Nikolaos Loakeimidis, Panagiotis Xaplanteris, Christos Georgakopoulos, Evangelia Sigala, Losif Koutagiar, Angeliki Rigatou, Dimitrios Tousoulis   +9 more
doaj   +1 more source

Sense of coherence and hypertensive target organ damage

Psychiatria Polska, 2019
Cel pracyNadciśnienie tętnicze może być powikłane uszkodzeniami narządowymi (oznaczanymi w języku angielskim skrótem TOD – target organ damage). Do chwili obecnej udało się zidentyfikować wiele różnych czynników powiązanych z rozwojem TOD. Jednak, zgodnie z naszą wiedzą, nie próbowano wyodrębnić zmiennych psychologicznych, które różnicują pacjentów z ...
Lech, Popiołek, Iwona, Gawlik, Olga, Siga, Anna, Dzieża-Grudnik, Małgorzata, Moląg, Paweł, Rodziński, Tomasz, Grodzicki, Jolanta, Walczewska, Krzysztof, Rutkowski   +8 more
openaire   +2 more sources

Infant Embryonal CNS Tumors: Molecular Insights and Treatment Considerations for Contemporary Pediatric Neuro‐Oncology

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Embryonal tumors comprise the majority of malignant central nervous system (CNS) neoplasms diagnosed in children under 3 years of age. Compared with their counterparts in older children, these tumors exhibit distinct molecular biology and a more aggressive clinical phenotype, while their management is complicated by the heightened ...
Sudarshawn Damodharan, Mariah Wright‐Nadkarni, Mohamed S. Abdelbaki, Girish Dhall   +3 more
wiley   +1 more source

Relaxin does not improve Angiotensin II-induced target-organ damage.

PLoS ONE, 2014
Relaxin is a corpus-luteum produced protein hormone with vasodilatatory, anti-fibrotic, and angiogenic properties that are opposite to angiotensin (Ang) II. We investigated whether or not relaxin ameliorates Ang II-induced target-organ damage.
Nadine Haase, Julianna Rugor, Lukasz Przybyl, Fatimunnisa Qadri, Dominik N Müller, Ralf Dechend   +5 more
doaj   +1 more source